Published • loading... • Updated
Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium ...
Summary by Hastings Tribune
2 Articles
2 Articles
Post RegisterReposted by 
Hastings Tribune
Hastings TribuneCeribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium ...
SUNNYVALE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced the commercial launch of its…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
